NEWPARK RESOURCES REPORTS FOURTH QUARTER 2022 RESULTS
Newpark Resources (NR) reported fourth-quarter 2022 revenues of $225.2 million, a rise from $219.9 million in Q3 2022 and $179.6 million in Q4 2021. Net income stood at $9.0 million, or $0.10 per diluted share, contributing $2.4 million from divestitures. Adjusted Net Income grew 27% sequentially to $0.07 per diluted share. The Industrial Solutions segment thrived with $57.5 million in revenue, while Fluids Systems saw a slight decline to $167.7 million, though operating income improved significantly. The company reduced debt by $47 million and plans to return value to shareholders through share repurchases.
- Total revenues increased to $225.2 million, up 2% from Q3 2022 and 25% year-over-year.
- Net income rose to $9.0 million, significantly improved from a net loss of $24.6 million in Q3 2022.
- Adjusted EBITDA improved by 9% sequentially to $21.5 million.
- Industrial Solutions segment revenue rose 12% sequentially, reaching $57.5 million, and operating income increased to $17.8 million.
- Debt reduced by $47 million in the fourth quarter.
- Fluids Systems segment revenue declined slightly to $167.7 million, impacted by operational inefficiencies from divestitures.
- The divested Excalibar operations contributed an operating loss of $2.9 million in Q4 2022.
Company reports revenues of
"Our strong operational execution was led by Industrial Solutions, where robust demand from the utilities sector contributed to a
Lanigan continued, "In Fluids Systems, while the fourth quarter was impacted by the partial-quarter results and some operational inefficiency associated with the divestitures, the
"Regarding cash flows, we generated roughly
"As we look to the year ahead, we expect to deliver solid Free Cash Flow, as we focus on executing our disciplined growth strategy, including the acceleration of our growth in the utilities sector, while also continuing to return excess cash generation to shareholders through additional share repurchases," concluded Lanigan.
Segment Results
The Industrial Solutions segment generated revenues of
The Fluids Systems segment generated revenues of
Conference Call
Newpark has scheduled a conference call to discuss fourth quarter of 2022 results and its near-term operational outlook, which will be broadcast live over the Internet, on
This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical facts are forward-looking statements. Words such as "will," "may," "could," "would," "should," "anticipates," "believes," "estimates," "expects," "plans," "intends," and similar expressions are intended to identify these forward-looking statements but are not the exclusive means of identifying them. These statements are not guarantees that our expectations will prove to be correct and involve a number of risks, uncertainties, and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents filed with the
Condensed Consolidated Statements of Operations |
(Unaudited) |
Three Months Ended | Twelve Months Ended | ||||||||
(In thousands, except per share data) | December | September | December | December | December | ||||
Revenues | $ 225,159 | $ 219,853 | $ 179,563 | $ 815,594 | $ 614,781 | ||||
Cost of revenues | 186,980 | 187,884 | 153,182 | 694,058 | 529,552 | ||||
Selling, general and administrative expenses | 24,648 | 24,207 | 26,690 | 97,618 | 94,445 | ||||
Other operating (income) loss, net | (3,995) | (345) | (250) | (4,370) | (391) | ||||
Impairments and other charges | — | 29,417 | — | 37,322 | — | ||||
Operating income (loss) | 17,526 | (21,310) | (59) | (9,034) | (8,825) | ||||
Foreign currency exchange (gain) loss | 2,332 | (1,424) | (314) | 389 | (397) | ||||
Interest expense, net | 2,321 | 1,875 | 2,057 | 7,040 | 8,805 | ||||
Loss on extinguishment of debt | — | — | — | — | 1,000 | ||||
Income (loss) before income taxes | 12,873 | (21,761) | (1,802) | (16,463) | (18,233) | ||||
Provision for income taxes | 3,881 | 2,834 | 1,879 | 4,371 | 7,293 | ||||
Net income (loss) | $ 8,992 | $ (24,595) | $ (3,681) | $ (20,834) | $ (25,526) | ||||
Calculation of EPS: | |||||||||
Net income (loss) - basic and diluted | $ 8,992 | $ (24,595) | $ (3,681) | $ (20,834) | $ (25,526) | ||||
Weighted average common shares outstanding - basic | 92,324 | 93,737 | 92,043 | 92,712 | 91,460 | ||||
Dilutive effect of stock options and restricted stock awards | 1,156 | — | — | — | — | ||||
Weighted average common shares outstanding - diluted | 93,480 | 93,737 | 92,043 | 92,712 | 91,460 | ||||
Net income (loss) per common share - basic: | $ 0.10 | $ (0.26) | $ (0.04) | $ (0.22) | $ (0.28) | ||||
Net income (loss) per common share - diluted: | $ 0.10 | $ (0.26) | $ (0.04) | $ (0.22) | $ (0.28) |
| |||||||||
Three Months Ended | Twelve Months Ended | ||||||||
(In thousands) | December | September | December | December | December | ||||
Revenues | |||||||||
Fluids Systems | $ 167,705 | $ 168,621 | $ 127,892 | $ 622,601 | $ 420,789 | ||||
Industrial Solutions | 57,454 | 51,232 | 51,138 | 192,993 | 185,171 | ||||
Industrial Blending | — | — | 533 | — | 8,821 | ||||
Total revenues | $ 225,159 | $ 219,853 | $ 179,563 | $ 815,594 | $ 614,781 | ||||
Operating income (loss) | |||||||||
Fluids Systems (1) | $ 4,828 | $ (24,193) | $ 932 | $ (15,566) | $ (19,012) | ||||
Industrial Solutions | 17,751 | 10,036 | 9,472 | 43,899 | 42,117 | ||||
Industrial Blending (2) | 2,322 | (526) | (1,115) | (8,002) | (2,384) | ||||
Corporate office | (7,375) | (6,627) | (9,348) | (29,365) | (29,546) | ||||
Total operating income (loss) | $ 17,526 | $ (21,310) | $ (59) | $ (9,034) | $ (8,825) | ||||
Segment operating margin | |||||||||
Fluids Systems | 2.9 % | (14.3) % | 0.7 % | (2.5) % | (4.5) % | ||||
Industrial Solutions | 30.9 % | 19.6 % | 18.5 % | 22.7 % | 22.7 % | ||||
Industrial Blending | NM | NM | NM | NM | (27.0) % |
(1) | Fluids Systems operating loss for the three months ended |
(2) | Industrial Blending operating income for the three months ended |
Summarized operating results (including impairments and other charges described above) of our now exited Excalibar business and
Three Months Ended | Twelve Months Ended | ||||||||
(In thousands) | December | September | December | December | December | ||||
Revenues | |||||||||
Excalibar | $ 11,922 | $ 17,623 | $ 10,816 | $ 55,990 | $ 36,396 | ||||
8,011 | 8,591 | 4,049 | 26,708 | 25,366 | |||||
Total revenues | $ 19,933 | $ 26,214 | $ 14,865 | $ 82,698 | $ 61,762 | ||||
Operating income (loss) | |||||||||
Excalibar | $ 1,127 | $ 888 | $ 385 | $ 3,665 | $ (277) | ||||
(4,023) | (32,931) | (2,257) | (43,215) | (6,753) | |||||
Total operating income (loss) | $ (2,896) | $ (32,043) | $ (1,872) | $ (39,550) | $ (7,030) |
Condensed Consolidated Balance Sheets |
(Unaudited) |
(In thousands, except share data) |
|
| |
ASSETS | |||
Cash and cash equivalents | $ 23,182 | $ 24,088 | |
Receivables, net | 242,247 | 194,296 | |
Inventories | 149,571 | 155,341 | |
Prepaid expenses and other current assets | 10,966 | 14,787 | |
Total current assets | 425,966 | 388,512 | |
Property, plant and equipment, net | 193,099 | 260,256 | |
Operating lease assets | 23,769 | 27,569 | |
47,110 | 47,283 | ||
Other intangible assets, net | 20,215 | 24,959 | |
Deferred tax assets | 2,275 | 2,316 | |
Other assets | 2,441 | 1,991 | |
Total assets | $ 714,875 | $ 752,886 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |||
Current debt | $ 22,438 | $ 19,210 | |
Accounts payable | 93,633 | 84,585 | |
Accrued liabilities | 46,871 | 46,597 | |
Total current liabilities | 162,942 | 150,392 | |
Long-term debt, less current portion | 91,677 | 95,593 | |
Noncurrent operating lease liabilities | 19,816 | 22,352 | |
Deferred tax liabilities | 8,121 | 11,819 | |
Other noncurrent liabilities | 9,291 | 10,344 | |
Total liabilities | 291,847 | 290,500 | |
Common stock, | 1,115 | 1,093 | |
Paid-in capital | 641,266 | 634,929 | |
Accumulated other comprehensive loss | (67,186) | (61,480) | |
Retained earnings | 2,489 | 24,345 | |
(154,656) | (136,501) | ||
Total stockholders' equity | 423,028 | 462,386 | |
Total liabilities and stockholders' equity | $ 714,875 | $ 752,886 |
Condensed Consolidated Statements of Cash Flows |
(Unaudited) |
Twelve Months Ended | |||
(In thousands) | 2022 | 2021 | |
Cash flows from operating activities: | |||
Net loss | $ (20,834) | $ (25,526) | |
Adjustments to reconcile net loss to net cash used in operations: | |||
Impairments and other non-cash charges | 37,322 | — | |
Depreciation and amortization | 38,610 | 42,225 | |
Stock-based compensation expense | 6,861 | 7,926 | |
Provision for deferred income taxes | (3,384) | (1,209) | |
Credit loss expense | 1,039 | 664 | |
Gain on divestitures | (3,596) | — | |
Gain on sale of assets | (2,809) | (7,182) | |
Gain on insurance recovery | — | (849) | |
Loss on extinguishment of debt | — | 1,000 | |
Amortization of original issue discount and debt issuance costs | 871 | 3,707 | |
Change in assets and liabilities: | |||
Increase in receivables | (42,452) | (61,283) | |
Increase in inventories | (46,909) | (10,336) | |
Increase in other assets | (855) | (726) | |
Increase in accounts payable | 10,781 | 36,341 | |
Increase in accrued liabilities and other | 334 | 12,235 | |
Net cash used in operating activities | (25,021) | (3,013) | |
Cash flows from investing activities: | |||
Capital expenditures | (28,273) | (21,793) | |
Proceeds from divestitures | 71,286 | — | |
Business acquisitions, net of cash acquired | — | (13,434) | |
Proceeds from sale of property, plant and equipment | 3,217 | 15,999 | |
Proceeds from insurance property claim | — | 1,753 | |
Net cash provided by (used in) investing activities | 46,230 | (17,475) | |
Cash flows from financing activities: | |||
Borrowings on lines of credit | 287,276 | 286,154 | |
Payments on lines of credit | (290,886) | (208,575) | |
Purchases of Convertible Notes | — | (28,137) | |
Payment on Convertible Notes | — | (38,567) | |
Proceeds from term loan | 3,754 | 8,258 | |
Proceeds from financing obligation | — | 8,004 | |
Debt issuance costs | (1,499) | (295) | |
Purchases of treasury stock | (20,248) | (1,448) | |
Other financing activities | (3,327) | (3,986) | |
Net cash provided by (used in) financing activities | (24,930) | 21,408 | |
Effect of exchange rate changes on cash | (707) | (1,779) | |
Net decrease in cash, cash equivalents, and restricted cash | (4,428) | (859) | |
Cash, cash equivalents, and restricted cash at beginning of period | 29,489 | 30,348 | |
Cash, cash equivalents, and restricted cash at end of period | $ 25,061 | $ 29,489 | |
Non-GAAP Reconciliations
(Unaudited)
To help understand the Company's financial performance, the Company has supplemented its financial results that it provides in accordance with generally accepted accounting principles ("GAAP") with non-GAAP financial measures. Such financial measures include Adjusted Net Income (Loss), Adjusted Net Income (Loss) Per Common Share, earnings before interest, taxes, depreciation and amortization ("EBITDA"), Adjusted EBITDA, Free Cash Flow, EBITDA Margin, Net Debt, and the
We believe these non-GAAP financial measures are frequently used by investors, securities analysts and other parties in the evaluation of our performance and liquidity with that of other companies in our industry. Management uses these measures to evaluate our operating performance, liquidity and capital structure. In addition, our incentive compensation plan measures performance based on our consolidated EBITDA, along with other factors. The methods we use to produce these non-GAAP financial measures may differ from methods used by other companies. These measures should be considered in addition to, not as a substitute for, financial measures prepared in accordance with GAAP.
Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Common Share
The following tables reconcile the Company's net income (loss) and net income (loss) per common share calculated in accordance with GAAP to the non-GAAP financial measures of adjusted net income (loss) and adjusted net income (loss) per common share:
Consolidated | Three Months Ended | Twelve Months Ended | |||||||
(In thousands) | December | September | December | December | December | ||||
Net income (loss) (GAAP) | $ 8,992 | $ (24,595) | $ (3,681) | $ (20,834) | $ (25,526) | ||||
Impairments and other charges | — | 29,417 | — | 37,322 | — | ||||
Gain on divestitures | (3,596) | — | — | (3,596) | — | ||||
Fourchon, | — | — | — | — | 2,596 | ||||
Facility exit costs and other | 1,303 | 526 | 708 | 2,860 | 2,399 | ||||
Severance costs | 216 | — | 201 | 736 | 1,898 | ||||
Gain on legal settlement | — | — | — | — | (1,000) | ||||
Loss on extinguishment of debt | — | — | — | — | 1,000 | ||||
Gain on insurance recovery | — | — | — | — | (849) | ||||
Tax expense (benefit) on adjustments | (318) | (110) | — | (755) | — | ||||
Tax benefit on restructuring of certain subsidiary legal entities | — | — | — | (3,111) | — | ||||
Adjusted net income (loss) (non-GAAP) | $ 6,597 | $ 5,238 | $ (2,772) | $ 12,622 | $ (19,482) | ||||
Adjusted net income (loss) (non-GAAP) | $ 6,597 | $ 5,238 | $ (2,772) | $ 12,622 | $ (19,482) | ||||
Weighted average common shares outstanding - basic | 92,324 | 93,737 | 92,043 | 92,712 | 91,460 | ||||
Dilutive effect of stock options and restricted stock awards | 1,156 | 446 | — | 1,300 | — | ||||
Weighted average common shares outstanding - diluted | 93,480 | 94,183 | 92,043 | 94,012 | 91,460 | ||||
Adjusted net income (loss) per common share - diluted (non-GAAP): | $ 0.07 | $ 0.06 | $ (0.03) | $ 0.13 | $ (0.21) | ||||
Non-GAAP Reconciliations (Continued)
(Unaudited)
EBITDA and Adjusted EBITDA
The following table reconciles the Company's net income (loss) calculated in accordance with GAAP to the non-GAAP financial measures of EBITDA and Adjusted EBITDA:
Consolidated | Three Months Ended | Twelve Months Ended | |||||||
(In thousands) | December | September | December | December | December | ||||
Net income (loss) (GAAP) | $ 8,992 | $ (24,595) | $ (3,681) | $ (20,834) | $ (25,526) | ||||
Interest expense, net | 2,321 | 1,875 | 2,057 | 7,040 | 8,805 | ||||
Provision (benefit) for income taxes | 3,881 | 2,834 | 1,879 | 4,371 | 7,293 | ||||
Depreciation and amortization | 8,351 | 9,696 | 10,216 | 38,610 | 42,225 | ||||
EBITDA (non-GAAP) | 23,545 | (10,190) | 10,471 | 29,187 | 32,797 | ||||
Impairments and other charges | — | 29,417 | — | 37,322 | — | ||||
Gain on divestitures | (3,596) | — | — | (3,596) | — | ||||
Fourchon, | — | — | — | — | 2,596 | ||||
Facility exit costs and other | 1,303 | 388 | 708 | 2,452 | 2,399 | ||||
Severance costs | 216 | — | 201 | 736 | 1,898 | ||||
Gain on legal settlement | — | — | — | — | (1,000) | ||||
Loss on extinguishment of debt | — | — | — | — | 1,000 | ||||
Gain on insurance recovery | — | — | — | — | (849) | ||||
Adjusted EBITDA (non-GAAP) | $ 21,468 | $ 19,615 | $ 11,380 | $ 66,101 | $ 38,841 | ||||
Free Cash Flow
The following table reconciles the Company's net cash provided by (used in) operating activities calculated in accordance with GAAP to the non-GAAP financial measure of the Company's free cash flow:
Consolidated | Three Months Ended | Twelve Months Ended | |||||||
(In thousands) |
|
|
|
|
| ||||
Net cash provided by (used in) | $ 3,072 | $ (5,082) | $ (16,683) | $ (25,021) | $ (3,013) | ||||
Capital expenditures | (10,553) | (8,205) | (2,690) | (28,273) | (21,793) | ||||
Proceeds from sale of property, | 720 | 554 | 4,269 | 3,217 | 15,999 | ||||
Free Cash Flow (non-GAAP) | $ (6,761) | $ (12,733) | $ (15,104) | $ (50,077) | $ (8,807) | ||||
Non-GAAP Reconciliations (Continued)
(Unaudited)
EBITDA Margin
The following tables reconcile the Company's segment operating income (loss) calculated in accordance with GAAP to the non-GAAP financial measures of EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin:
Fluids Systems | Three Months Ended | Twelve Months Ended | |||||||
(In thousands) | December | September | December | December | December | ||||
Revenues | $ 167,705 | $ 168,621 | $ 127,892 | $ 622,601 | $ 420,789 | ||||
Operating income (loss) (GAAP) | $ 4,828 | $ (24,193) | $ 932 | $ (15,566) | $ (19,012) | ||||
Depreciation and amortization | 2,358 | 3,598 | 4,292 | 13,875 | 17,877 | ||||
EBITDA (non-GAAP) | 7,186 | (20,595) | 5,224 | (1,691) | (1,135) | ||||
Impairments and other charges | — | 29,417 | — | 29,417 | — | ||||
Gain on divestiture | (971) | — | — | (971) | — | ||||
Fourchon, | — | — | — | — | 2,596 | ||||
Facility exit costs and other | 1,000 | — | 708 | 1,000 | 2,399 | ||||
Severance costs | 163 | — | 152 | 398 | 1,329 | ||||
Gain on insurance recovery | — | — | — | — | (849) | ||||
Adjusted EBITDA (non-GAAP) | $ 7,378 | $ 8,822 | $ 6,084 | $ 28,153 | $ 4,340 | ||||
Operating Margin (GAAP) | 2.9 % | (14.3) % | 0.7 % | (2.5) % | (4.5) % | ||||
Adjusted EBITDA Margin (non-GAAP) | 4.4 % | 5.2 % | 4.8 % | 4.5 % | 1.0 % |
Industrial Solutions | Three Months Ended | Twelve Months Ended | |||||||
(In thousands) | December | September | December | December | December | ||||
Revenues | $ 57,454 | $ 51,232 | $ 51,138 | $ 192,993 | $ 185,171 | ||||
Operating income (GAAP) | $ 17,751 | $ 10,036 | $ 9,472 | $ 43,899 | $ 42,117 | ||||
Depreciation and amortization | 5,482 | 5,367 | 4,960 | 21,653 | 19,304 | ||||
EBITDA (non-GAAP) | 23,233 | 15,403 | 14,432 | 65,552 | 61,421 | ||||
Severance costs | 53 | — | 49 | 214 | 302 | ||||
Gain on legal settlement | — | — | — | — | (1,000) | ||||
Adjusted EBITDA (non-GAAP) | $ 23,286 | $ 15,403 | $ 14,481 | $ 65,766 | $ 60,723 | ||||
Operating Margin (GAAP) | 30.9 % | 19.6 % | 18.5 % | 22.7 % | 22.7 % | ||||
Adjusted EBITDA Margin (non-GAAP) | 40.5 % | 30.1 % | 28.3 % | 34.1 % | 32.8 % |
Non-GAAP Reconciliations (Continued) |
(Unaudited) |
Industrial Blending | Three Months Ended | Twelve Months Ended | |||||||
(In thousands) | December | September | December | December | December | ||||
Revenues | $ — | $ — | $ 533 | $ — | $ 8,821 | ||||
Operating income (loss) (GAAP) | $ 2,322 | $ (526) | $ (1,115) | $ (8,002) | $ (2,384) | ||||
Depreciation and amortization | — | 138 | 270 | 678 | 1,095 | ||||
EBITDA (non-GAAP) | 2,322 | (388) | (845) | (7,324) | (1,289) | ||||
Impairment | — | — | — | 7,905 | — | ||||
Gain on divestiture | (2,625) | — | — | (2,625) | — | ||||
Facility exit costs and other | 303 | 388 | — | 1,453 | — | ||||
Severance costs | — | — | — | 123 | 61 | ||||
Adjusted EBITDA (non-GAAP) | $ — | $ — | $ (845) | $ (468) | $ (1,228) | ||||
The following table reconciles the Company's ratio of total debt to capital calculated in accordance with GAAP to the non-GAAP financial measure of the Company's ratio of net debt to capital:
(In thousands) |
|
| |
Current debt | $ 22,438 | $ 19,210 | |
Long-term debt, less current portion | 91,677 | 95,593 | |
Total Debt | 114,115 | 114,803 | |
Total stockholders' equity | 423,028 | 462,386 | |
Total Capital | $ 537,143 | $ 577,189 | |
21.2 % | 19.9 % | ||
Total Debt | $ 114,115 | $ 114,803 | |
Less: cash and cash equivalents | (23,182) | (24,088) | |
Net Debt | 90,933 | 90,715 | |
Total stockholders' equity | 423,028 | 462,386 | |
Total Capital, Net of Cash | $ 513,961 | $ 553,101 | |
17.7 % | 16.4 % |
Contacts: | Senior Vice President and 281-362-6800 | |
View original content:https://www.prnewswire.com/news-releases/newpark-resources-reports-fourth-quarter-2022-results-301749167.html
SOURCE
FAQ
What were Newpark Resources' (NR) fourth-quarter 2022 revenues?
How much net income did Newpark Resources generate in Q4 2022?
What improvements did Newpark Resources see in their Adjusted EBITDA for Q4 2022?
What challenges did Newpark Resources face in their Fluids Systems segment for Q4 2022?